The effect of cannabinoid receptor agonist WIN 55,212–2 on anxiety‐like behavior and locomotion in a genetic model of absence seizures in the elevated plus‐maze

Absence seizures and their relationship to depression and anxiety: Evidence for bidirectionality

(2021) Benjamin F. Gruenbaum et al.   EPILEPSIA

Positive allosteric modulation of type 1 cannabinoid receptors reduces spike-and-wave discharges in Genetic Absence Epilepsy Rats from Strasbourg

(2021) Andrew J. Roebuck et al.   NEUROPHARMACOLOGY

Clinical and experimental insight into pathophysiology, comorbidity and therapy of absence seizures

(2020) Vincenzo Crunelli et al.   BRAIN

Altered SWD stopping mechanism in WAG/Rij rats subchronically treated with the cannabinoid agonist R(+)WIN55,212-2

(2019) Martin F.J. Perescis et al.   EPILEPSY & BEHAVIOR

Role for serotonin2A (5-HT2A) and 2C (5-HT2C) receptors in experimental absence seizures

(2016) Marcello Venzi et al.   NEUROPHARMACOLOGY

The Genetic Absence Epilepsy Rats from Strasbourg model of absence epilepsy exhibits alterations in fear conditioning and latent inhibition consistent with psychiatric comorbidities in humans

(2015) Wendie N. Marks et al.   EUROPEAN JOURNAL OF NEUROSCIENCE

Anxiety and locomotion in Genetic Absence Epilepsy Rats from Strasbourg (GAERS): Inclusion of Wistar rats as a second control

(2014) José Eduardo Marques-Carneiro et al.   EPILEPSIA

WAG/Rij rats show a reduced expression of CB1 receptors in thalamic nuclei and respond to the CB1 receptor agonist, R(+)WIN55,212-2, with a reduced incidence of spike-wave discharges

(2010) Clementina M. Van Rijn et al.   EPILEPSIA

A genetic epilepsy rat model displays endophenotypes of psychosis

(2010) Nigel C. Jones et al.   NEUROBIOLOGY OF DISEASE